🧠 Mood Stabilizer Selection Simulator

Identifying the Current Illness Phase

Placeholder: phase drives every downstream drug choice.

• 3: Phases tracked (mania, depression, maintenance)
• Mood state: Key input (placeholder metric)
• Ongoing: Reassessment (placeholder cadence)
• Clinical exam: Tool (placeholder source)

Why phase matters first

Placeholder text: phase sets the treatment target before any drug is picked.

Lithium Suitability Across Phase and Comorbidity

Placeholder: lithium is strong in mania and maintenance, weaker in depression.

• Mania: Best phase (placeholder strength)
• High: Renal risk (placeholder caution)
• Levels: Monitoring (placeholder need)
• Notable: Anti-suicide effect (placeholder benefit)

Lithium strengths and cautions

Placeholder text: renal and thyroid comorbidity lower the lithium score sharply.

Valproate Suitability Across Phase and Comorbidity

Placeholder: valproate excels acutely in mania, less so in depression.

• Mania: Best phase (placeholder strength)
• Moderate: Hepatic risk (placeholder caution)
• Avoid: Pregnancy (placeholder restriction)
• Fast: Onset (placeholder speed)

Valproate strengths and cautions

Placeholder text: hepatic comorbidity moderately lowers the valproate score.

Lamotrigine Suitability Across Phase and Comorbidity

Placeholder: lamotrigine favors depression and maintenance, weak in mania.

• Depression: Best phase (placeholder strength)
• Slow: Titration (placeholder pace)
• Low-mod: Rash risk (placeholder caution)
• Minimal: Comorbidity impact (placeholder tolerance)

Lamotrigine strengths and cautions

Placeholder text: comorbidity burden barely changes the lamotrigine score.

Combining Phase and Comorbidities into a Recommendation

Placeholder: the highest suitability score wins the final pick.

• 2: Inputs used (phase and comorbidity)
• 3 scores: Outputs (one per agent)
• Max score: Decision rule (placeholder logic)
• Periodic: Review (placeholder cadence)

Reading the final recommendation

Placeholder text: reassess as phase shifts or comorbidities change.

Placeholder highlight: no single agent wins every scenario.